1. Home
  2. TG vs SLGL Comparison

TG vs SLGL Comparison

Compare TG & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

N/A

Current Price

$7.94

Market Cap

262.4M

Sector

Industrials

ML Signal

N/A

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$77.40

Market Cap

254.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TG
SLGL
Founded
1988
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.4M
254.1M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
TG
SLGL
Price
$7.94
$77.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$110.00
AVG Volume (30 Days)
172.2K
42.7K
Earning Date
05-08-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
N/A
EPS
0.34
N/A
Revenue
$800,821,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$223.84
P/E Ratio
$23.44
N/A
Revenue Growth
8.29
N/A
52 Week Low
$6.25
$21.00
52 Week High
$10.53
$97.97

Technical Indicators

Market Signals
Indicator
TG
SLGL
Relative Strength Index (RSI) 52.41 45.69
Support Level $7.29 $67.89
Resistance Level $8.20 $81.18
Average True Range (ATR) 0.38 6.36
MACD -0.01 -0.91
Stochastic Oscillator 22.60 32.93

Price Performance

Historical Comparison
TG
SLGL

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Share on Social Networks: